首页|期刊导航|中国老年保健医学|血清同型半胱氨酸联合血脂水平预测老年动脉粥样硬化性脑梗死中长期预后的研究

血清同型半胱氨酸联合血脂水平预测老年动脉粥样硬化性脑梗死中长期预后的研究OA

Study on the medium-and long-term prognostic value of serum homocysteine combined with blood lipid levels in elderly patients with atherosclerotic cerebral infarction

中文摘要英文摘要

目的 探讨血清同型半胱氨酸(HCY)联合血脂水平对老年首次发病动脉粥样硬化性脑梗死中长期预后的预测价值.方法 本研究为单中心回顾性纵向队列研究,初筛2022 年3 月至2023 年3 月于我院神经内科住院的脑卒中患者1227例,按照纳入排除标准递进式筛选,最终纳入首次发病时间为2015 年1 月1 日至2024 年6 月30 日、末次随访时间不晚于2024 年6 月30 日的老年动脉粥样硬化性脑梗死患者90 例.收集患者基线(首次发病入院72h 内)及全随访期的血液检测指标,主要包括 HCY、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白 A1(APOA)、载脂蛋白 B(APOB)、非传统血脂参数(CHR=TC/HDL-C、LHR=LDL-C/HDL-C、ABR=APOA/APOB)、脂蛋白a(LPa)、血尿酸(UA)检测数据,以全随访期mRS 评分动态变化为中长期终点,将患者分为预后维持组(mRS 无升高或降低,n=58)和预后恶化组(mRS 升高≥1 分,n=32).采用混合线性模型(LMM)分析各指标与预后的纵向关联,通过多因素 Logistic 回归构建联合预测模型,采用 ROC 曲线评估指标的预后预测效能.结果 混合线性模型显示,HCY 的预后分组主效应具有显著统计学意义(F=9.19,P=0.003),且时间效应无统计学意义(P>0.05),是唯一与预后独立相关且水平稳定的生物标志物.ROC 曲线分析显示,HCY 单项指标对预后不良的判别AUC 值为0.625,HCY 联合TG 和基线NIHSS 评分的联合模型 AUC 值提升至0.787,预测效能显著提升.结论 HCY 是老年首次发病动脉粥样硬化性脑梗死患者长期神经功能恶化风险的独立稳定预测标志物,联合血脂指标与临床神经功能评分可显著提升预后分层判别能力,为卒中全程管理提供参考.

Objective To explore the predictive value of serum homocysteine(HCY)combined with blood lipid levels for the medium-and long-term prognosis of elderly patients with first-onset atherosclerotic cerebral infarction.Methods This was a single-center retrospective longitudinal cohort study.A total of 1,227 stroke patients admitted to the Department of Neurology of our hospital from March 2022 to March 2023 were initially screened.After strict stepwise screening based on inclusion and exclusion criteria,90 elderly patients with first-onset atherosclerotic cerebral infarction(onset after January 1,2015,with the last follow-up conducted no later than June 30,2024)were finally enrolled.Baseline data(collected within72 hours after the first onset)and longitudinal follow-up data of multiple indicators were collected,including serum HCY,total cholesterol(TC),triglyceride(TG),high-density lipopro-tein cholesterol(HDL-C),low-density lipoprotein cholesterol(LDL-C),apolipoprotein A1(APOA),apolipoprotein B(APOB),non-traditional lipid parameters[TC/HDL-C(CHR),LDL-C/HDL-C(LHR),APOA/APOB(ABR)],lipoprotein(a)(LPa),and uric acid(UA).According to the dynamic changes in the modified Rankin Scale(mRS)score during follow-up,patients were divid-ed into two groups:the prognosis maintenance group(with unchanged or decreased mRS scores,n=58)and the prognosis deteriora-tion group(with an mRS score increase of≥1 point,n=32).A linear mixed model(LMM)was applied to analyze the longitudinal association between each indicator and patient prognosis.Multivariate Logistic regression was used to construct a combined prediction model,and receiver operating characteristic(ROC)curve analysis was performed to evaluate the prognostic efficacy of the indica-tors.Results The linear mixed model analysis revealed that the main effect of HCY on prognosis grouping was statistically signifi-cant(F=9.19,P=0.003),whereas the time effect was not significant(P>0.05).HCY was identified as the only independent and stable biomarker associated with patient prognosis.ROC curve analysis showed that the area under the curve(AUC)of single HCY for predicting poor prognosis was 0.625.The combined model incorporating HCY,TG and baseline NIHSS score yielded an in-creased AUC of 0.787,with markedly improved predictive efficacy.Conclusion HCY serves as an independent and stable predic-tive biomarker for long-term neurological deterioration in elderly patients with first-onset atherosclerotic cerebral infarction.The com-bination of HCY,blood lipid indicators and clinical neurological function scores can significantly enhance prognostic stratification ca-pability,which provides a reference for the whole-course clinical management of stroke patients.

利荣乔;梁硕林;罗莉颖;周琴

广西壮族自治区江滨医院 检验科 530021广西壮族自治区江滨医院 神经内科 530021广西壮族自治区江滨医院 检验科 530021广西壮族自治区江滨医院 检验科 530021

动脉粥样硬化性脑梗死中长期预后血清同型半胱氨酸混合线性模型联合预测模型

atherosclerotic cerebral infarctionmedium-and long-term prognosisserum homocysteinelinear mixed modelcombined prediction model

《中国老年保健医学》 2026 (4)

35-40,6

广西壮族自治区卫生健康委员会自筹经费科研课题(编号:Z-A20220250)

10.3969/j.issn.1672-2671.2026.04.006

评论